Rose McCormack

Rose McCormack is a Drug Development Consultant at Innate Pharma with extensive experience in oncology drug development.1 She is an accomplished pharmaceutical professional who has expertise in research, clinical biomarker science, and diagnostic team leadership.

Some key points about Rose McCormack:

• She is currently working as a Drug Development Consultant at Innate Pharma.1
• Rose has experience as a Program and Portfolio Leader in the pharmaceutical industry.1
• She has a background in oncology drug development.1
• McCormack is pursuing an eMBA (Executive MBA) degree.2
• Her LinkedIn profile indicates she has connections to Dublin City University.1

Prior to her role at Innate Pharma, Rose McCormack worked at AstraZeneca, where she contributed to research on topics like EGFR mutation prevalence in advanced non-small cell lung cancer patients.3

Rose appears to be actively involved in Innate Pharma's work on immunotherapy and innovative medicines, as evidenced by her engagement with company posts about their symposiums and future outlook.2